Display options
Share it on

Ulus Cerrahi Derg. 2014 Dec 25;32(2):145-8. doi: 10.5152/UCD.2014.2153. eCollection 2016.

Recurrent renal giant leiomyosarcoma.

Ulusal cerrahi dergisi

Salih Erpulat Öziş, Kamil Gülpınar, Zafer Şahlı, Baha Burak Konak, Mete Keskin, Süleyman Özdemir, Ömür Ataoğlu

Affiliations

  1. Department of General Surgery, Ufuk University School of Medicine, Ankara, Turkey.
  2. Department of Pathology, Private Mikro-Pat Laboratory, Ankara, Turkey.

PMID: 27436926 PMCID: PMC4942162 DOI: 10.5152/UCD.2014.2153

Abstract

Primary renal leiomyosarcomas are rare, aggressive tumors. They constitute 1-2% of adult malignant renal tumors. Although leiomyosarcomas are the most common histological type (50-60%) of renal sarcomas, information on renal leiomyosarcoma is limited. Local or systemic recurrences are common. The radiological appearance of renal leiomyosarcomas is not specific, therefore renal leiomyosarcoma cannot be distinguished from renal cell carcinoma by imaging methods in all patients. A 74-year-old female patient presented to our clinic complaining of a palpable mass on the right side of her abdomen in November 2012. The abdominal magnetic resonance imaging revealed a mass, 25 × 24 × 23 cm in size. Her past medical history revealed that she has undergone right radical nephrectomy in 2007, due to a 11 × 12 × 13 cm renal mass that was then reported as renal cell carcinoma on abdominal magnetic resonance imaging, but the pathological diagnosis was low-grade renal leiomyosarcoma. The most recent follow-up of the patient was in 2011, with no signs of local recurrence or distant metastases within this four-year period. The patient underwent laparotomy on November 2012, and a 35 cm retroperitoneal mass was excised. The pathological examination of the mass was reported as high-grade leiomyosarcoma. The formation of this giant retroperitoneal mass in 1 year can be explained by the transformation of the lesion's pathology from low-grade to a high-grade tumor.

Keywords: Leiomyosarcoma; kidney; recurrence

References

  1. Cancer. 1993 Feb 1;71(3):804-10 - PubMed
  2. Arch Ital Urol Androl. 1999 Dec;71(5):307-11 - PubMed
  3. Am J Surg Pathol. 2010 Feb;34(2):238-42 - PubMed
  4. Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):783-95 - PubMed
  5. Yonsei Med J. 2007 Jun 30;48(3):557-60 - PubMed
  6. Curr Opin Oncol. 2010 Jul;22(4):356-61 - PubMed
  7. Gynecol Obstet Invest. 2005;59(1):36-40 - PubMed
  8. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;43(1):86-90 - PubMed
  9. Histopathology. 2002 Apr;40(4):353-9 - PubMed
  10. PLoS One. 2011;6(8):e20294 - PubMed
  11. Nat Med. 2007 Jun;13(6):748-53 - PubMed
  12. Ann Surg. 2006 Aug;244(2):289-95 - PubMed
  13. Urol Ann. 2010 Jan;2(1):36-8 - PubMed

Publication Types